BioMedWire Stocks Archives - BioMedWire (BMW)

FridayApr 25, 2025 10:00 am

Scientists ID Bacteria That Could Be Behind Multiple Sclerosis Development

A new study focusing on twins has found that individuals with a larger presence of certain bacteria types could have a higher likelihood of developing multiple sclerosis. These findings could offer new ways to halt the disease’s progression or prevent it altogether. The team was led by researchers based at Ludwig Maximilian University in Munich and they discovered that two specific kinds of bacteria occurred more frequently in individuals diagnosed with MS, and those same kinds of bacteria were present in mice that developed this condition. The bacteria in question are Lachnoclostridium and Eisenbergiella tayi, the team indicated in their…

ThursdayApr 24, 2025 10:00 am

How Stem Cells Help in Blood Cancer Treatment

Stem cells are the “master cells” within the body because they can grow into any needed type of specialized cell in one’s body. As cancer treatment advances, these cells are proving to be a lifesaver for many people diagnosed with blood cancers like leukemia, myeloma and lymphoma. MGM Cancer Institute’s hemato-oncologist Doctor Gopinath explains that stem cells play the role of making all blood cells by producing platelets, white blood cells and red blood cells. Each of these types of cells plays a critical role in survival. For example, white blood cells fight infections while red blood cells transport needed…

TuesdayApr 22, 2025 10:00 am

UnitedHealth Records Lower Revenue as Medical Advantage Use Grows

UnitedHealth Group, the largest health insurance firm in the U.S., has reduced its revenue forecast for 2025 after its customers on Medicare Advantage made use of their policies a lot more than the company had anticipated. The first quarter of the year registered a lower financial performance than the company had expected. The stocks of the firm tumbled after this news on Thursday and the report released shook insurance stocks across the board. UnitedHealth said that MA plans saw more activity than the company had projected for the year. This was particularly evident in outpatient services and doctor visits, all…

MondayApr 21, 2025 10:00 am

Study Finds Link Between Childhood Maltreatment and Elevated Risk of Psoriasis, Rheumatoid Arthritis

A new study whose findings appeared in the journal Heliyon has found that individuals that suffered neglect, abuse and other forms of maltreatment during their childhood had a notably elevated risk of being diagnosed with chronic immune-related disorders later on in their lives. Psoriasis and rheumatoid arthritis were particularly noted in the study subjects and women exhibited a higher likelihood of developing these immune disorders. The researchers were interested in investigating whether exposure to abuse early in life had a connection with inflammatory disorders that are immune system mediated, such as multiple sclerosis, rheumatoid arthritis, inflammatory bowel conditions, and psoriasis.…

ThursdayApr 17, 2025 10:00 am

The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035

The global market for brain tumor treatments is experiencing significant transformation powered by advances in immunotherapy, personalized medicine and targeted therapy. The market is projected to grow at a 7.2% CAGR to reach $7.15 billion by 2035, according to a report published by Future Market Insights. The report indicates that this market is entering a new phase of growth propelled by the increasing prevalence of malignant brain tumors, such as glioblastoma, in addition to a remarkable increase in investments in the neuro-oncology field. Many cutting-edge interventions are being integrated in the way patients are treated. These include tumor-treating fields and…

TuesdayApr 15, 2025 10:00 am

New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection

A team of researchers has developed a “cost-effective” and simple blood test with the potential to detect Parkinson’s disease years before the disease’s symptoms start manifesting. The study’s findings appeared in the Nature Aging journal. Approximately 153,000 individuals live with Parkinson’s disease in the United Kingdom, and the team that conducted this recent research is optimistic that their innovation could revolutionize how early the disease can be detected. This early diagnosis would then allow treatment teams to initiate interventions that improve the clinical outcomes for patients. The new test developed focuses on analyzing fragments of transfer RNA (tRFs), which are…

FridayApr 11, 2025 10:00 am

Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy

Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that blocking the HPGDS enzyme can be a viable way to improve patients’ response to immunotherapy since the activity of this enzyme contributes to immunotherapy resistance. This approach can also increase immunotherapy response in other types of cancer with similar attributes to those of melanoma. Over the last 10 years, significant advances have been made in leveraging immunotherapy to treat melanoma and other cancers. However, more than half (65%) of melanoma patients don’t respond to immunotherapy. TAMs (tumor-associated macrophages) play a major role in this immunotherapy…

ThursdayApr 10, 2025 10:00 am

Health Insurance Shares Climb After Medicare Reimbursements are Boosted

Shares of health insurance firms in the U.S. jumped after the federal government announced a reimbursement rate increase which was higher than what had been expected by the industry. The rate increase applies to Medicare Advantage plans and will take effect next year. This increase was welcome news to the industry that had seen their margins squeezed by rising costs of medical care. Humana, an insurer specializing in Medicare, saw its shares soar by 16% while other firms, such as Centene, UnitedHealth Group and CVS saw upticks ranging from 5% to 10%. After the Covid-19 pandemic, there was a surge…

TuesdayApr 08, 2025 10:00 am

Study Shows the Gut is Key in Protecting the Brain After Stroke

Many patients who have had a stroke often suffer secondary brain damage as a result of the inflammation that is triggered during the stroke. Scientists have been working to find ways to forestall this secondary brain damage and a recent preclinical study conducted by a team at UTHealth Houston could provide a viable way to address neuroinflammation after stroke episodes. For their study, the team focused on molecules whose role is to bind to particular receptors. These molecules are called ligands, mainly produced in the gut. Ligands are vital in facilitating cell function and signaling between different parts of the…

MondayApr 07, 2025 10:00 am

Study Uncovers Drivers of Brain Tumor Growth, Could Open New Treatment Approaches

A new study has uncovered key drivers of brain cancer growth that could make it possible to predict or even slow down the rate at which these tumors regrow. This could open a new chapter in personalized cancer treatment. The research team, led by Professor Parag Katira of San Diego State University, together with Moffit Cancer Center’s Ana Gomes and Noemi Andor, discovered how brain tumor cells grow and transform in response to the environment in which they find themselves. These findings could enable doctors to predict the cancer’s response to any treatments to be administered. The team focused their…